ONE REASON that transgender medicine is such a fraught matter is that there’s little proof behind the arguments. When Hilary Cass, a British paediatrician, reviewed the sector for an influential report revealed in 2024, she famous that many of the science underlying the prescription of puberty blockers and cross-sex hormones to youngsters (an method referred to as “gender-affirming care”) was “remarkably weak”.
